On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration regarding its Citizen Petition…
Aimed Alliance’s Counsel, Ashira Vantrees, will be speaking to employers at the Ohio Rare Disease Summit on “Managing Prescription Drug…
On March 18, 2024, Aimed Alliance hosted a webinar on Prescription Drug Affordability Boards (PDABs) titled “PDAB 101: Everything You…
The Florida Senate recently voted to restrict the sale of intoxicating cannabinoid products. SB 1698 addresses health and safety concerns…
On September 29, 2023, the United States District Court for the District of Columbia held that the 2021 NBPP, which…
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease: Improving Treatment While Working Toward…
On Aug. 11, 2023, Aimed Alliance released a new Easy-Read Know Your Rights brochure for patients with Movement Disorders. An…
Optum, a pharmacy benefit manager (PBM), recently published an article on some of the risks associated with alternative funding programs.…
Aimed Alliance Counsel, Ashira Vantrees, was recently quoted in a Health Central article on how consumers with chronic conditions can…